Clinical trials
Recruiting Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 14 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 5 |
| Mayo Clinic | 3 |
| University of Texas Southwestern Medical Center | 3 |
| Brigham and Women's Hospital | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| Intellia Therapeutics | 2 |
| Peking University First Hospital | 2 |
| Tianjin Medical University | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 53 |
| Amyloid Neuropathies, Familial | 16 |
| Immunoglobulin Light-chain Amyloidosis | 12 |
| Cardiomyopathies | 8 |
| Amyloidosis, Familial | 7 |
| Polyneuropathies | 7 |
| Multiple Myeloma | 6 |
| Alzheimer Disease | 5 |
| Amyloid Neuropathies | 3 |
| Heart Failure | 3 |
Trials
Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.